Publication | Closed Access

Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial

Oracle MsOral CladribineNeurological DisorderClinical NeurologyClinical TrialsNeurological ProgressNeurological MonitoringNeurologyMultiple SclerosisMedicineNeuroimmunology